Dependence on electron transport chain function and intracellular signaling of genomic responses in SH-SY5Y cells to the mitochondrial neurotoxin MPP+

Experimental Neurology

Volumn 181, Issue 1, 2003, Pages 25-38

  Brill II, Louis B ^a   Bennett Jr , James P ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; Methylpyridinium; Microarray; Mitochondria; Neuroblastoma; Parkinsonism

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COMPLEMENTARY DNA; METHYLPYRIDINIUM ION; NEUROTOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN C JUN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; UO 126;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC MARKER; GENOME; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN; UNINDEXED SEQUENCE;

EID: 0037403845     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00045-6     Document Type: Article

References (47)

1. Abramova N.A., Cassarino D.S., Khan S.M., Painter T.W., Bennett J.P. Jr. Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. J. Neurosci. Res. 67:2002;494-500.
2. Ballard P.A., Tetrud J.W., Langston J.W. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) seven cases. Neurology. 35:1985;949-956.
3. Barone M.V., Crozat A., Tabaee A., Philipson L., Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8:1994;453-464.
4. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
5. Bindoff L.A., Birch-Machin M., Cartilidge N.E., Parker W.D. Jr., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104:1991;203-208.
6. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
7. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. 1:1999;1-25.
8. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parker W.D. Jr., Bennett J.P. Jr. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta. 1362:1997;77-86.
9. Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker W.D. Jr., Sturgill T.W., Bennett J.P. Jr. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. J. Neurochem. 74:2000;1384-1392.
10. Chiba K., Trevor A., Castagnoli N. Metabolism of the neurotoxic tertiary amine. MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:1984;547-578.
11. Conn K.J., Gao W.W., Ullman M.D., McKeon-O'Malley C., Eisenhauer P.B., Fine R.E., Wells J.M. Specific up-regulation of GADD153/CHOP in 1-methyl-4-phenyl-pyridinium-treated SH-SY5Y cells. J. Neurosci. Res. 68:2002;755-760.
12. Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., Kopin I.J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr. Res. 1:1979;249-254.
13. Dehmer T., Lindenau J., Haid S., Dichgans J., Schulz J.B. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74:2000;2213-2216.
14. Dennis, J., Bennett, Jr., J.P., 2002. Interaction among nitric oxide and Bcl-family proteins in a neural cell-based MPP+ model of Parkinson's disease I. J. Neurosci Res. (In press).
15. +-induced apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 55:1999;620-628.
16. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
17. Fawcett T.W., Eastman H.B., Martindale J.L., Holbrook N.J. Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress. J. Biol. Chem. 271:1996;14285-14289.
18. Frangiskakis J.M., Ewart A.K., Morris C.A., Mervis C.B., Bertrand J., Robinson B.F., Klein B.P., Ensing G.J., Everett L.A., Green E.D., Proschel C., Gutowski N.J., Noble M., Atkinson D.L., Odelberg S.J., Keating M.T. LIM-kinase 1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell. 86:1996;59-69.
19. Graeber M.B., Moran L.B. Mechanisms of cell death in neurodegenerative diseases fashion, fiction, and facts. Brain Pathol. 12:2002;385-390.
20. Halvorsen E.M., Dennis J., Keeney P.M., Sturgill T.W., Tuttle J.B., Bennett J.P. Jr. Methypyridinium (MPP+)- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells. Brain Res. 952:2002;98-110.
21. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA. 82:1985;2173-2177.
22. Jenner P., Rupniak N.M., Rose S., Kelly E., Kilpatrick G., Lees A., Marsden C.D. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50:1984;85-90.
23. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
24. Langston J.W., Langston E.B., Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol. Scand. Suppl. 100:1984;49-54.
25. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science. 294:2001;1945-1948.
26. Luethy J.D., Holbrook N.J. Activation of the gadd153 promoter by genotoxic agents a rapid and specific response to DNA damage. Cancer Res. 52:1992;5-10.
27. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:1999;895-898.
28. Mandir A.S., Przedborski S., Jackson-Lewis V., Wang Z.Q., Simbulan-Rosenthal C.M., Smulson M.E., Hoffman B.E., Guastella D.B., Dawson V.L., Dawson T.M. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. USA. 96:1999;5774-5779.
29. Mann V.M., Cooper J.M., Kriige D., Daniel S.E., Schapira A.H.V., Marsden D. Brain, skeletal muscle, and platelet homogenate mitochondrial functions in Parkinson's disease. Brain. 115:1992;333-342.
30. Matsumoto M., Minami M., Takeda K., Sakao Y., Akira S. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett. 395:1996;143-147.
31. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kagawa Y. Deficiencies of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163:1989;1450-1455.
32. Mytilineau C., Werner P., Molinari S., DiRocco A., Cohen G., Yahr M.D. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 8:1994;223-228.
33. Nakayama K. Furin a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:1997;625-635.
34. Nicklas W.J., Vyas I., Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 8:1985;223-228.
35. Offen D., Beart P.M., Cheung N.S., Pascoe C.J., Hochman A., Gorodin S., Melamed E., Bernard R., Bernard O. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:1998;5789-5794.
36. Parker W.D. Jr., Boyson S.I., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26:1989;719-723.
37. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
38. Qiao D., Im E., Qi W., Martinez J.D. Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis. Biochim. Biophys. Acta. 1583:2002;108-116.
39. Snyder S.H., D'Amato R.J. MPTP a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture. Neurology. 36:1986;250-258.
40. Stephans S.E., Miller G.W., Levey A.I., Greenamyre J.T. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology. 23:2002;569-580.
41. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett J.P. Jr., Davis R.E., Parker W.D. Jr. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:1996;663-671.
42. Trimmer P.A., Smith T.S., Jung A.B., Bennett J.P. Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration. 5:1996;233-239.
43. Veech G.A., Dennis J., Keeney P.M., Fall C.P., Swerdlow R.H., Parker W.D. Jr., Bennett J.P. Jr. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. J. Neurosci. Res. 61:2000;693-700.
44. Vila M., Jackson-Lewis V.V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S.J., Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA. 98:2001;2837-2842.
45. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
46. Yang L., Matthews R.T., Schulz J.B., Klockgether T., Liao A.W., Martinou J.C., Penney J.B. Jr., Hyman B.T., Beal M.F. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. 18:1998;8145-8152.
47. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12:1998;982-995.